A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Abemaciclib in Dedifferentiated Liposarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
- Status
- COMPLETED
- Phase
- PHASE1
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2